Herbalife price target lowered to $11 from $13 at Citi

Citi lowered the firm’s price target on Herbalife (HLF) to $11 from $13 and keeps a Buy rating on the shares following the Q1 report. Total Herbalife new distributor growth remained solid at 16% year-over-year, but the North America trend inflected negative compounding questions about the timeline for a U.S. sales inflection, the analyst tells investors in a research note. However, Citi remains positive on the company’s ongoing balance sheet deleverage with potential for accelerating interest cost reductions in 2026.